Traws Pharma, Inc. - TRAW
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Chief Science Officer Virology | A | A | 97,000.0 | 0.0 | 0.0 | 97,000.0 | View | |
| Jul 15, 2026 | — | A | A | 14,150.0 | 0.0 | 0.0 | 14,150.0 | View | |
| Jul 15, 2026 | Chief Operating Officer | A | A | 93,000.0 | 0.0 | 0.0 | 93,000.0 | View | |
| Jul 14, 2026 | — | A | A | 14,150.0 | 0.0 | 0.0 | 14,150.0 | View | |
| Jul 14, 2026 | Chief Executive Officer | A | A | 274,000.0 | 0.0 | 0.0 | 274,000.0 | View | |
| Jul 14, 2026 | Chief Medical Officer | A | A | 84,000.0 | 0.0 | 0.0 | 84,000.0 | View | |
| Jul 14, 2026 | Chief Financial Officer | A | A | 90,000.0 | 0.0 | 0.0 | 90,000.0 | View | |
| Jul 14, 2026 | — | A | A | 14,150.0 | 0.0 | 0.0 | 14,150.0 | View | |
| Jul 14, 2026 | — | A | A | 14,150.0 | 0.0 | 0.0 | 14,150.0 | View | |
| Jul 14, 2026 | — | A | A | 14,150.0 | 0.0 | 0.0 | 14,150.0 | View | |
| Apr 28, 2026 | — | P | A | 1,793,187.0 | — | — | 1,793,187.0 | View | |
| Apr 28, 2026 | — | P | A | 597,729.0 | — | — | 597,729.0 | View | |
| Apr 28, 2026 | — | P | A | 597,729.0 | — | — | 597,729.0 | View | |
| Apr 28, 2026 | — | P | A | 597,729.0 | 1.67 | 998,207.43 | 1,203,250.0 | View | |
| Apr 08, 2026 | Chief Financial Officer | A | A | 104,544.0 | 0.0 | 0.0 | 104,544.0 | View | |
| Apr 08, 2026 | Chief Financial Officer | A | A | 61,571.0 | 0.0 | 0.0 | 61,571.0 | View | |
| Apr 08, 2026 | Chief Financial Officer | A | A | 32,406.0 | 0.0 | 0.0 | 32,406.0 | View | |
| Apr 08, 2026 | Chief Financial Officer | A | A | 15,393.0 | 0.0 | 0.0 | 15,393.0 | View |